PubMed · 2001 · 43 citations · 29 references
Life SciencesGeneticsOncologyCancer GeneticsGenomicsMolecular OncologyCancer GenomicsLoss Of HeterozygosityMolecular CytogeneticsOvarian CancerOvarian NeoplasiaTumor Suppressor GenesChromosomal RearrangementsLoss Of Heterozygosity AnalysisLoss Of Heterozygosity MappingMicrosatellite MarkersPrimary Ovarian CarcinomaTumor Suppressor Gene DeletionsTumor Suppressor LossWhole-genome Amplification
Investigation of genetic changes in tumors by loss of heterozygosity is a powerful technique for identifying chromosomal regions that may contain tumor suppressor genes. In this study, we determined allelic loss on chromosomes 5 and 6 in 29 primary early-stage epithelial ovarian carcinomas including 3 microscopically identified adenocarcinomas using a high-throughput PCR-based method combined with laser capture microdissection and whole genome amplification techniques. Twenty microsatellite markers spanning chromosomes 5 and 6 at an average distance of 20 cM were examined. High frequencies of loss on chromosome 5 were identified at loci D5S428 (48%), D5S424 (32%), and D5S630 (32%). Our study also showed that chromosome 6 exhibited high frequencies of loss of heterozygosity at loci D6S1574 (46%), D6S287 (42%), D6S441 (45%), D6S264 (60%), and D6S281 (35%). These results suggest that multiple tumor suppressor genes are located on five distinct regions on chromosomes 5 and 6, i.e., 5p15.2, 5q13-21, 6p24-25, 6q21-23, and 6q25.1-27, and may be involved in the early development of ovarian carcinomas.
29
Allelotype of human ovarian cancer.
Takaaki Sato, Hiroko Saito, Ryoji Morita et al. · PubMed · 1991 · 256 citations
Life Sciences, Genetics, Oncology +17
Human epithelial ovarian cancer allelotype.
William A. Cliby, S Ritland, Lynn C. Hartmann et al. · PubMed · 1993 · 242 citations
Life Sciences, Genetics, Oncology +11